<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02385370</url>
  </required_header>
  <id_info>
    <org_study_id>92181</org_study_id>
    <nct_id>NCT02385370</nct_id>
  </id_info>
  <brief_title>Bleb Function and Morphology With Intratendon Injection of MMC Compared With Standard Method</brief_title>
  <acronym>conj mmc</acronym>
  <official_title>Bleb Function and Morphology With Intratendon Injection of 0.1 mg MMC in Comparison With Conventional Subtenon Application of 0.02% MMC Soaked Sponges in Trabeculectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shahid Beheshti University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shahid Beheshti University of Medical Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with advanced glaucoma that are candidates for trabeculectomy will be included.

      Thorough ophthalmic examination including best corrected visual acuity, slit lamp
      examination, intraocular pressure (IOP) measurement, gonioscopy, funduscopy and specularly
      microscopy will be performed for all participants. Patients will be assigned randomly to 2
      groups. In one group they will undergo fornix based trabeculectomy with conventional MMC
      0.02% soaked sponges application. In the other group 0.1 cc of 0.01 MMC will be injected into
      the tenon at the beginning of the surgery. The rest of the operation is the same for both
      groups as standard trabeculectomy. Ophthalmic examination including IOP measurement will be
      performed at one, 3 and 6th month post surgery. Specular microscopy will be requested at
      final follow up visit. Bleb morphology will be scored according to Indian grading system at
      3rd and 6th months post surgery.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2014</start_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>IOP (intraocular pressure)</measure>
    <time_frame>until 6 months</time_frame>
    <description>Goldmann applanation tonometry</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bleb morphology</measure>
    <time_frame>until 6 months</time_frame>
    <description>scoring the bleb morphologic features according to Indian Grading System</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">126</enrollment>
  <condition>Glaucoma</condition>
  <arm_group>
    <arm_group_label>using standard method of applying MMC</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>applying MMC 0.02 % soaked sponges under conjunctival space for 1 to 3 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>intratendon injection of MMC</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>intratendon injection of 0.1 cc MMC 0.01% at the beginning of the procedure</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>MMC</intervention_name>
    <description>using 0.02 MMC soaked sponged under the conjunctiva for 1 to 3 minutes</description>
    <arm_group_label>using standard method of applying MMC</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>MMC</intervention_name>
    <description>0.1 cc of 0.01% MMC is injected into the tenon.</description>
    <arm_group_label>intratendon injection of MMC</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Advanced uncontrolled glaucoma patients.

        Exclusion Criteria:

          -  History of any kind of intraocular surgery.

          -  Monocular patients.

          -  Unwillingness to participate in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>mohammad pakravan</last_name>
    <phone>009822591616</phone>
    <email>labbafi@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <address>
        <city>Tahran</city>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>mohammad pakravan</last_name>
      <phone>009822591616</phone>
      <email>labbafi@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 4, 2015</study_first_submitted>
  <study_first_submitted_qc>March 10, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 11, 2015</study_first_posted>
  <last_update_submitted>March 10, 2015</last_update_submitted>
  <last_update_submitted_qc>March 10, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 11, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shahid Beheshti University of Medical Sciences</investigator_affiliation>
    <investigator_full_name>Zahra Rabbani Khah</investigator_full_name>
    <investigator_title>Shahid Beheshti Medical University</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

